Europa Trial
Home
Sitemap
General Public Heathcare Professionals Virtual Press Office

New Indication in CAD

EUROPA calendar
ACC 2006 - Posters
ESC 2005 - Symposium
ESC 2005 - Oral sessions
ESC 2005 - Posters
AHA 2004 - Oral Session
ESC 2004 - Hotline
ESC 2004 - Symposium
ACC 2004
ESC 2003


EUROPA study
EUROPA Results
ESC 2003 Hotline - video
Rationale for EUROPA
Rationale for Perindopril
Design & Organisation
EUROPA investigators
EUROPA collaborating centres
EUROPA Recruitment


EUROPA Slide Set
Rationale and Design
Results
Clinical Implications


EUROPA publications


PERSUADE
PERSUADE Publications
PERSUADE Results
PERSUADE Fact Sheet


PERTINENT
PERTINENT Results
PERTINENT Fact Sheet


Background : Coronary Artery Disease
Home : Healthcare professionals : EUROPA investigators
EUROPA investigators




EUROPA CHAIRMEN


Name Country
Prof Fox Co Chairman, United Kingdom
Prof Remme Co Chairman, The Netherlands



EXECUTIVE COMMITTEE


Chairman,
United Kingdom
France
Italy
The Netherlands
The Netherlands


EUROPA STEERING COMMITTEE


Name Country Name Country
Chairman, The Netherlands
Prof Aldershvile Denmark Prof Bassand France
Prof Cokkinos Greece Prof Eha Estonia
Prof Erhardt Sweden Prof Erikssen Norway
Prof Grybauskas Lithuanian Republic Prof Hildebrandt Denmark
Prof Kalnins Latvia Prof Karsch Germany
Prof Keltai Hungary Prof Klein Austria
Prof Lüscher Switzerland Prof Mulcahy Ireland
Prof Nieminen Finland Prof Oto Turkey
Prof Ozsaruhan Turkey Prof Paulus Belgium
Prof Providencia Portugal Prof Riecansky Slovakia
Prof Ruzyllo Poland Prof Santini Italy
Prof Sechtem Germany Prof Soler-Soler Spain
Prof Tavazzi Italy Prof Toutouzas Greece
Prof Widimsky Czech Republic    


EUROPA SAFETY COMMITTEE

Name Country
Prof Julian Chairman, United Kingdom
Prof Dargie United Kingdom
Prof Kübler Germany
Prof Murray United Kingdom


ENDPOINT VALIDATION COMMITTEE

Name Country
Prof Thygesen Chairman, Denmark
Prof Duprez Belgium
Prof Steg France


This website is intended for an international audience. Drug related information may refer to unlicensed products or uses which may not be approved in your own country and you should therefore consult your local prescribing information.
This site is published and updated by the EUROPA study investigators. Site last updated March 21st 2006
To report a suspected side-effect with a Servier drug, please click here.
Terms of use - ©2005 EUROPA All rights reserved